COVID 2021 Part II, Workforce Impact By: Chuck Vollmer, Jobenomics Founder & President 16 January 2020 The coronavirus could be more destructive to the U.S. workforce in 2021 than in 2020. Download This Report Executive Summary Most Americans are ready to put the pandemic in their rearview mirror and look forward to a new year […] The post COVID 2021, Part II, Workforce Impact appeared first on Jobenomics.| Jobenomics
The pandemic provides a unique opportunity to create a more equitable society—by returning to the frontier-style capitalism that gives ordinary citizens the means to be self-sufficient and independent. Frontier-style capitalism and startup business ownership in underserved communities are underlying Jobenomics principles that grew into an international grassroots movement with chapters in four continents in less than a decade. The post COVID 2021, Part I, Scenarios appeared first on Jobenom...| Jobenomics
The process to create medicines and treatments for new infectious diseases and autoimmune diseases is slow and expensive, sometimes taking more than a decade and billions of dollars to bring a drug to market. Can AI (artificial intelligence) help speed antibody drug discovery? New university research aims to help accelerate medical response. A $3.1 million [...] The post Success Stories: AI and Antibodies Collide first appeared on Connected World.| Connected World
Get ready for monoclonal antibody targeted vaccines!| www.natureofhealing.org